Specifically, alterations in ATRX were significantly enriched in the top quartile of soft tissue liposarcoma (Bonferroni-corrected p < 0.01, odds ratio (OR) = 2.7 [1.7–4.2]) and soft tissue sarcoma not otherwise specified (nos, Bonferroni-corrected p < 0.01, OR = 2.0 [1.4–2.6], Fig. 1B and Table S2). This evidence concerns the gene ATRX and soft tissue sarcoma.